T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Neurocrine Biosciences
NBIX
$15.3B
| $170M | 0.03% |
1,425,290
-38,124
| -3% | -$4.47M |
|
402
Scholastic
SCHL
$784M
| $169M | 0.03% |
4,270,918
+27,184
| +0.6% | +$1.01M |
|
403
IBM
IBM
$223B
| $168M | 0.03% |
1,189,674
+16,911
| +1% | +$2.33M |
|
404
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $167M | 0.03% |
1,699,074
+25,300
| +2% | +$2.41M |
|
405
United Rentals
URI
$69.7B
| $167M | 0.03% |
468,864
-146,865
| -24% | -$48.3M |
|
406
Xometry
XMTR
$5.42B
| $166M | 0.03% |
5,164,512
-87,766
| -2% | -$4.1M |
|
407
American Homes 4 Rent
AMH
$12.3B
| $165M | 0.03% |
5,485,408
-117,081
| -2% | -$3.71M |
|
408
monday.com
MNDY
$3.99B
| $165M | 0.03% |
1,351,331
+42,128
| +3% | +$4.38M |
|
409
Oracle
ORCL
$450B
| $165M | 0.03% |
2,014,883
+37,698
| +2% | +$2.86M |
|
410
Freeport-McMoran
FCX
$93.6B
| $163M | 0.03% |
4,287,587
-1,585
| -0% | -$55.4K |
|
411
Ionis Pharmaceuticals
IONS
$9.28B
| $162M | 0.03% |
4,292,431
-504,701
| -11% | -$21.2M |
|
412
Strategic Education
STRA
$1.86B
| $162M | 0.03% |
2,067,898
+28,746
| +1% | +$2.13M |
|
413
ScottsMiracle-Gro
SMG
$3.59B
| $162M | 0.03% |
3,330,654
+1,283,911
| +63% | +$64.3M |
|
414
Terreno Realty
TRNO
$7.5B
| $161M | 0.03% |
2,836,013
-482,103
| -15% | -$27.1M |
|
415
Corning
GLW
$137B
| $159M | 0.03% |
4,986,993
-326,970
| -6% | -$10.6M |
|
416
NovoCure
NVCR
$2.02B
| $159M | 0.03% |
2,168,431
-203,555
| -9% | -$15.3M |
|
417
C.H. Robinson
CHRW
$17.5B
| $158M | 0.03% |
1,724,319
-330,980
| -16% | -$31.5M |
|
418
PPG Industries
PPG
$25.5B
| $157M | 0.03% |
1,252,432
-4,803
| -0.4% | -$588K |
|
419
Cheniere Energy
LNG
$55B
| $157M | 0.03% |
1,043,975
+200,609
| +24% | +$33.6M |
|
420
3M
MMM
$94.2B
| $157M | 0.03% |
1,561,081
-14,431
| -0.9% | -$1.47M |
|
421
Ameriprise Financial
AMP
$50.4B
| $155M | 0.03% |
498,824
+275,720
| +124% | +$84.1M |
|
422
Bath & Body Works
BBWI
$3.76B
| $154M | 0.02% |
3,660,557
+1,416,667
| +63% | +$52.8M |
|
423
Incyte
INCY
$24.4B
| $154M | 0.02% |
1,920,289
-386,583
| -17% | -$29.6M |
|
424
Intel
INTC
$527B
| $153M | 0.02% |
5,783,731
+67,303
| +1% | +$1.87M |
|
425
Atmos Energy
ATO
$28.7B
| $152M | 0.02% |
1,356,020
+18,354
| +1% | +$2.02M |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.